Viatris

VTRS · NASDAQ

$18.65+$0.39 (+2.14%)TodayMarket closed ·
Prev close $18.26

About VTRS

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania and currently employs 30,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.

Employees
30,000
Headquarters
Canonsburg, Pennsylvania
Listed
Feb 1, 1973
Sector
Health Care
Industry
Pharmaceuticals

Leadership

Viatris executives
NameTitleSince
Melina Higgins——
Scott Smith—2022
Mark Parrish——
Theodora Mistras——
Paul Campbell——
Andrew Enrietti——
Corinne Le Goff——
Matthew Maletta——
Brian Roman——
Hemanth Varghese——
Rajiv Malik—2020
Rogerio Coelho——
Wyllie Cornwell——
Frank D'Amelio——
JoEllen Dillon——
Elisha Finney——
Leo Groothuis——
James Kilts——
Harry Korman——
Richard Mark——
Michael Severino——
David Simmons——

Revenue by product and region

Fiscal year ended Dec 31, 2025: $14.25B total revenue

By product

  • Brands$9.18B64.4%
  • Generics$5.07B35.6%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Viatris suppliers and customers
CompanyRelationshipCorrelation
Bausch Health BHCSupplier and customer0.75
Vivimed LabsSupplier0.72
LupinSupplier and customer0.70
SMS PharmaceuticalsSupplier0.69
Sonoma Pharmaceuticals SNOASupplier0.64
NATCO PharmaSupplier0.64
UniFirst UNFSupplier0.63
Evofem Biosciences EVFMSupplier and customer0.62
Titan Pharmaceuticals TTNPSupplier and customer0.61
Mabion MAB.WASupplier0.61

Similar companies

Companies in the same industry as Viatris

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.